Optivise Advisory Services’s Aspire Biopharma Holdings, Inc. Common Stock ASBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$63.2K Buy
235,106
+128,660
+121% +$34.6K 0.03% 205
2025
Q1
$62K Buy
+106,446
New +$62K 0.03% 195